Skip to content

High Intensity Focused Ultrasound for Uterine Leiomyoma and Adenomyosis

High Intensity Focused Ultrasound for Uterine Leiomyoma and Adenomyosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029619
Enrollment
Unknown
Registered
2020-02-07
Start date
2020-02-10
Completion date
Unknown
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine leiomyoma and adenomyosis

Interventions

Hysteromyoma group:High intensity focused ultrasoud
Adenomyosis group:High intensity focused ultrasoud

Sponsors

Beijing Friendship Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. The patients had been diagnosed with uterus leiomyoma and adenomyosis by clinical symptoms, magnetic resonance imaging (MRI) and ultrasonography. 2. Blood routine: neutrophils (>1.5 *10^9/L), platelets (>100 *10^9/L) and hemoglobin (>90 g/L). 3. Have symptoms which related to uterine fibroids or adenomyosis, have the willings to receive this treatment. Leiomyomas: diameter >= 3cm and = 3cm and <= 10cm. 4. Ultrasound energy can spread completely.

Exclusion criteria

Exclusion criteria: 1. With the history of gynecologic malignant tumor. 2. Patients with connective tissue disorder or any foreign bodies in ultrasound energy channels. 3. Patients with bacterial vaginosis. 4. Pregnancy or desiring be pregnancy. 5. Has contraindication of MRI. 6. Central nervous system diseases, psychiatric disorders, unstable angina pectoris, congestive heart failure, severe arrhythmia and other serious uncontrollable diseases. 7. Any condition that may impair patient safety or integrity of research data, including serious medical risk factors, medical conditions, and laboratory abnormalities. 8. The patient is unwilling or unable to follow the research procedure, or may be separated from the observation for one course or more during the course of the study.

Design outcomes

Primary

MeasureTime frame
volume of uterus;volume of leiomyomas;the thickness of endometrium measured by ultrasound;morphology of uterine cavity;

Secondary

MeasureTime frame
CA125;UFS-QOL;estrogen;progestin;follicle-stimulating hormone;androgen;prolactin;luteinizing hormone;

Countries

China

Contacts

Public ContactQian Linxue

Beijing Friendship Hospital Affiliated to Capital Medical University

qianlxyyyy@163.com+86 13311100999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026